UCB Biosciences recalls

FDA enforcement reports naming UCB Biosciences Inc. as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: May 27, 2026

Severity

May 27, 2026cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Ma…Drug · UCB Biosciences Inc.Lack of Assurance of SterilityClass II